LEO Pharma A/S, a global medical dermatology leader, will present new data at the European Society of Contact Dermatitis (ESCD) Congress 2026 in Copenhagen. The findings will underscore the severity of chronic hand eczema (CHE) and call attention to ongoing gaps in patient care.